{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:55:46Z","timestamp":1762865746212},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1097\/hjh.0b013e328341885d","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T13:02:11Z","timestamp":1291122131000},"page":"396-399","source":"Crossref","is-referenced-by-count":28,"title":["Are angiotensin-converting enzyme inhibitors and angiotensin receptor blockers safe in pregnancy: a report of ninety-one pregnancies"],"prefix":"10.1097","volume":"29","author":[{"given":"Vellore J","family":"Karthikeyan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin E","family":"Ferner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabah","family":"Baghdadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deirdre A","family":"Lane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory YH","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D Gareth","family":"Beevers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-31-20210208","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/hyp.38.4.827","article-title":"Improved hypertension management and control: results from the Health Survey for England 1998","volume":"38","author":"Primatesta","year":"2001","journal-title":"Hypertension"},{"key":"R2-31-20210208","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/sj.jhh.1001683","article-title":"Guidelines for the management of hypertension: report of the fourth working party of the British Hypertension Society, 2004 - BHS IV.","volume":"18","author":"Williams","year":"2004","journal-title":"J Human Hypertens"},{"key":"R3-31-20210208","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens"},{"key":"R4-31-20210208","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and treatment of High Blood Pressure.","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"R5-31-20210208","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/tera.1420440503","article-title":"ACE inhibitor fetopathy and hypocalvaria: the kidney-skull connection","volume":"44","author":"Barr","year":"1991","journal-title":"Teratology"},{"key":"R6-31-20210208","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/pds.796","article-title":"Adverse pregnancy outcomes associated with maternal enalapril antihypertensive treatment","volume":"12","author":"Tabacova","year":"2003","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"R7-31-20210208","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0140-6736(05)64207-9","article-title":"Angiotensin-converting enzyme inhibitors in early pregnancy","volume":"350","author":"Lip","year":"1997","journal-title":"Lancet"},{"key":"R8-31-20210208","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/sj.jp.7210766","article-title":"Pregnancy with prolonged fetal exposure to an angiotensin-converting-enzyme inhibitor","volume":"22","author":"Muller","year":"2002","journal-title":"J Perinatol"},{"key":"R9-31-20210208","first-page":"128","article-title":"Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy","volume":"78","author":"Hanssens","year":"1991","journal-title":"Obstet Gynecol"},{"key":"R10-31-20210208","first-page":"570","article-title":"Exposure to angiotensin-converting enzyme inhibitors during first trimester: is it sake to fetus?","volume":"77","author":"Yip","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R11-31-20210208","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1056\/NEJMoa055202","article-title":"Major congenital malformations after first-trimester exposure to ACE inhibitors","volume":"354","author":"Cooper","year":"2006","journal-title":"N Engl J Med"},{"key":"R12-31-20210208","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0140-6736(00)03648-5","article-title":"Losartan and fetal toxic effects","volume":"357","author":"Saji","year":"2001","journal-title":"Lancet"},{"key":"R13-31-20210208","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10641950601147937","article-title":"Angiotensin II receptor blockers in pregnancy: a case report and systematic review of the literature","volume":"26","author":"Velazquez-Armenta","year":"2007","journal-title":"Hypertens Pregnancy"},{"key":"R14-31-20210208","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/bmj.301.6752.587","article-title":"Atenolol inessential hypertension during pregnancy","volume":"301","author":"Butters","year":"1990","journal-title":"BMJ"},{"key":"R15-31-20210208","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0002-9149(97)00163-X","article-title":"Effect of atenolol on birth weight","volume":"79","author":"Lip","year":"1997","journal-title":"Am J Cardiol"},{"key":"R16-31-20210208","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1161\/HYPERTENSIONAHA.106.075895","article-title":"Update on the use of antihypertensive drugs in pregnancy","volume":"51","author":"Podymow","year":"2008","journal-title":"Hypertension"},{"key":"R17-31-20210208","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00006250-200208000-00029","article-title":"Chronic hypertension in pregnancy","volume":"100","author":"Sibai","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R18-31-20210208","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"}],"container-title":["Journal of Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HJH.0b013e328341885d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T19:37:17Z","timestamp":1621885037000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004872-201102000-00031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/hjh.0b013e328341885d","relation":{},"ISSN":["0263-6352"],"issn-type":[{"value":"0263-6352","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}